Significance of the CAG repeat polymorphism of the androgen receptor gene in prostate cancer progression

Journal of Urology

Volumn 164, Issue 2, 2000, Pages 567-572

  Nam, Robert K ^a   Elhaji, Youssef ^a   Krahn, Murray D ^a   Hakimi, Jalil ^a   Ho, Minnie ^a   Chu, William ^a   Sweet, Joan ^a   Trachtenberg, John ^a   Jewett, Michael A S ^a   Narod, Steven A ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b NONE   (Canada)

Author keywords

Androgen receptor gene; Prognosis; Prostatic neoplasms

Indexed keywords

ANDROGEN RECEPTOR;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; DNA POLYMORPHISM; GENE REPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY;

EID: 18344409972     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)67424-1     Document Type: Article

References (45)

1. Potosky, A. L., Miller, B. A., Albertsen, P. C. and Kramer, B. S.: The role of increasing detection in the rising incidence of prostate cancer. JAMA, 273: 548, 1995
2. Canadian Cancer Statistics. Toronto: National Cancer Institute, 1997
3. Nam, R. K., Jewett, M. A. S. and Krahn, M. D.: Prostate cancer. 2. Natural history. CMAJ, 159: 685, 1998
4. Lu-Yao, G. L. and Yao, S. L.: Population-based study of long-term survival in patients with clinically localised prostate cancer. Lancet, 349: 906, 1997
5. Gerber, G. S., Thisted, R. A., Scardino, P. T., Frohmuller, H. G., Schroeder, F. H., Paulson, D. F., Middleton, A. W., Jr., Rukstalis, D. B., Smith, J. A., Jr., Schellhammer, P. F., Ohori, M. and Chodak, G. W.: Results of radical prostatectomy in men with clinically localized prostate cancer. JAMA, 276: 615, 1996
6. Albertsen, P. C., Fryback, D. G., Storer, B. E., Kolon, T. F. and Fine, J.: Long-term survival among men with conservatively treated localized prostate cancer. JAMA, 274: 626, 1995
7. Chodak, G. W., Thisted, R. A., Gerber, G. S., Johansson, J. E., Adolfsson, J., Jones, G. W., Chisholm, G. D., Moskovitz, B., Livne, P. M. and Warner, J.: Results of conservative management of clinically localized prostate cancer. New Engl J Med, 330: 242, 1994
8. Zagars, G. K., Ayala, A. G., von Eschenbach, A. C. and Pollack, A.: The prognostic importance of Gleason grade in prostatic adenocarcinoma: a long-term follow-up study of 648 patients treated with radiation therapy. Int J Radiat Oncol Biol Phys, 31: 237, 1995
9. Dillioglugil, O., Leibman, B. D., Kattan, M. W., Seale-Hawkins, C., Wheeler, T. M. and Scardino, P. T.: Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer. Urology, 50: 93, 1997
10. Zincke, H., Bergstralh, E. J., Blute, M. L., Myers, R. P., Barrett, D. M., Lieber, M. M., Martin, S. K. and Oesterling, J. E.: Radical prostatectomy for clinically localized prostate cancer: long-term results of 1143 patients from a single institution. J Clin. Oncol, 12: 2254, 1994
11. Catalona, W. J. and Smith, D. S.: Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: intermediate-term results. J Urol, 160: 2428, 1998
12. Ross, R. K., Pike, M. C., Coetzee, G. A., Reichardt, J. K. V., Yu, M. C., Feigelson, H., Stanczyk, F. Z., Kolonel, L. N. and Henderson, B. E.: Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility. Cancer Res, 58: 4497, 1998
13. Giovannucci, E., Stampfer, M. J., Krithivas, K., Brown, M., Brufsky, A., Talcott, J., Hennekens, C. H. and Kantoff, P. W.: The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci USA, 94: 3320, 1997
14. Ingles, S. A., Ross, R. K., Yu, M. C., Irvine, R. A., La Pera, G., Haile, R. W. and Coetzee, G. A.: Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. JNCI, 89: 166, 1997
15. Stanford, J. L., Just, J. J., Gibbs, M., Wicklund, K. G., Neal, C. L., Blumenstein, B. A. and Ostrander, E. A.: Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res, 57: 1194, 1997
16. Coetzee, G. A.: Prostate cancer and the androgen receptor. JNCI, 86: 872, 1994
17. Jenster, G., van der Korput, H. A. G. M., van Vroonhoven, C., van der Kwast, T. H., Trapman, J. and Brinkmann, A. O.: Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization. Mol Endocrinol, 5: 1396, 1991
18. Edwards, A., Hammond, H. A., Jin, L., Caskey, C. T. and Chakraborty, R.: Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics, 12: 241, 1992
19. Kazemi-Esfarjani, P., Trifiro, M. A. and Pinksy, L.: Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the CAG expanded neuronopathies. Hum Mol Genet, 4: 523, 1995
20. Chamberlin, N. L., Driver, E. D. and Miesfield, R. L.: The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain effect transactivation function. Nucleic Acids Res, 22: 3181, 1994
21. La Spada, A. R., Wilson, E. M., Lubahn, D. B., Harding, A. E. and Fichbeck, K. H.: Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature, 352: 77, 1991
22. Nagashima, T., Seko, K. and Hirose, K.: Familial bulbo-spinal muscular atrophy associated with testicular atrophy and sensory neuropathy: autopsy case report of two brothers. J Neurol Sci, 87: 141, 1988
23. Tut, T. G., Ghadessy, F. J., Trifiro, M. A., Pinsky, L. and Yong, E. L.: Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility. J Clin Endocrinol Metab, 82: 3777, 1997
24. Tincello, D. G., Saunders, P. T. and Hargreave, T. B.: Preliminary investigations on androgen receptor gene mutations in infertile men. Mol Hum Reprod, 3: 941, 1997
25. Pound, C. R., Partin, A. W., Eisenberger, M. A., Chan, D. W., Pearson, J. D. and Walsh, P. C.: Natural history of progression after PSA elevation following radical prostatectomy. JAMA, 281: 1591, 1999
26. Gleason, D. F. and Mellinger, G. T.: Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol, 111: 58, 1974
27. Klocker, H., Culing, Z., Hobisch, a., Hittmair, A., Bartsch, G., Peterziel, H. and Cato, A. C. B.: Androgen receptor mutations in prostate cancer. In: Molecular Biology of Prostate Cancer. Edited by M. Wirth, J. E. Altwein, B. Schmitz-Drager, and S. Kuptz. pp 81-88, New York: Walter de Gruyter, 1998
28. Sun, Z., Pan, J. and Balk, S. P.: Androgen receptor-associated protein complex binds upstream of the androgen-responsive elements in the promoters of human prostate-specific antigen and kallikrein 2 genes. Nucleic Acids Res, 25: 3318, 1997
29. Young, C. Y. F., Montgomery, B. T., Andrews, P. E., Qiu, S., Bilhartz, D. L. and Tindall, D. J.: Hormonal regulation of prostate-specific antigen (PSA) in the human adenocarcinoma cell line, LNCaP. Prostate, 21: 63, 1992
30. Wood, D. P., Banks, E. R., Humphreys, S., McRoberts, J. W. and Rangnekar, V. M.: Identification of bone marrow micrometastases in patients with prostate cancer. Cancer, 74: 2533, 1994
31. Seiden, M. V., Kantoff, P. W. and Krithivas, K.: Detection of circulating tumor cells in men with localized prostate cancer. J Clin Oncol, 12: 2634, 1994
32. Suzuki, H., Sato, N., Watabe, Y., Masai, M., Seino, S. and Shimazaki, J.: Androgen receptor gene mutations in human prostate cancer. J Steroid Biochem Mol Biol, 46: 759, 1993
33. Suzuki, H., Akakura, K., Komiya, A., Aida, S., Akimoto, S. and Shimazaki, J.: Codon 877 mutation in the androgen receptor gene in advanced prostate cancer: relation to antiandrogen withdrawal syndrome. Prostate, 29: 153, 1996
34. Sadi, M. V. and Barrack, E. R.: Image analysis of androgen receptor immunostaining in metastatic prostate cancer. Cancer, 71: 2574, 1993
35. Bolla, M., Gonzalez, D., Warde, P., Dubois, J. B., Mirimanoff, R-O., Storme, G., Bernier, J., Kuten, A., Sternberg, C., Gil, T., Collette, L. and Pierart, M.: Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. New Engl J Med, 337: 295, 1997
36. Lange, P. H., Ercole, C. J., Lightner, D. J., Fraley, E. E. and Vessella, R.: The value of serum prostate specific antigen determinations before and after radical prostatectomy. J Urol, 141: 873, 1989
37. Patel, A., Dorey, F., Franklin, J. and deKernion, J. B.: Recurrence patterns after radical retropubic prostatectomy: clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen. J Urol, 158: 1441, 1997
38. Catalona, W. J., Smith, D. S., Ratiff, T. L. and Basler, J. W.: Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA, 270: 948, 1993
39. Lange, P. H., Lightner, D. J., Medini, E., Reddy, P. K. and Vessella, R. L.: The effect of radiation therapy after radical prostatectomy in patients with elevated prostate specific antigen levels. J Urol, 144: 927, 1990
40. McCarthy, J. F., Catalona, W. J. and Hudson, M. A.: Effect of radiation therapy on detectable serum prostate specific antigen levels following radical prostatectomy: early versus delayed treatment. J Urol, 151: 1575, 1994
41. Morgan, W. R., Zincke, H., Rainwater, L. M., Myers, R. P. and Klee, G. G.: Prostate specific antigen values after radical retropubic prostatectomy for adenocarcinoma of the prostate: impact of adjuvant treatment (hormonal and radiation). J Urol, 145: 319, 1991
42. Buskirk, S. J., Schild, S. E., Durr, E. D., Robinow, J. S., Bock, F. F., Wolfe, J. T., Tomera, K. M. and Ferrigni, R. G.: Evaluation of serum prostate-specific antigen levels after postoperative radiation therapy for pathologic stage T3, NO prostate cancer. Mayo Clin Proc, 71: 242, 1996
43. Robinow, J. S., Schild, S. E., Tomera, K. M., Wolfe, J. T. and Buskirk, S. J.: Postoperative prostate specific antigen levels in pathologic stage C adenocarcinoma of the prostate in patients treated with radical prostatectomy alone [Abstract]. International J Radiat Oncol Biol Phys (Suppl), 27: 228, 1993
44. Partin, A. W., Borland, R. N., Epstein, J. I. and Brendler, C. B.: Influence of wide excision of the neurovascular bundle(s) on prognosis in men with clinically localized prostate cancer with established capsular penetration. J Urol, 150: 142, 1993
45. Stein, A., deKernion, J. B., Dorey, F. and Smith, R. B.: Adjuvant radiotherapy in patients post-radical prostatectomy with tumor extending through capsule or positive seminal vesicles. Urology, 39: 59, 1992